CordenPharma and Viking Therapeutics sign multi-year strategic partnership to support the commercial demand of Viking Therapeutics' GLP-1 drug candidate VK2735.CordenPharma provides large-scale ...
Leadership transition comes as Company focuses on clinical evaluation of its novel Ovarian Rebalancing technology, a one-time transvaginal ablation procedure designed to restore ovulation in ...
Vanotech Ltd, a pharmaceutical company devoted to greatly improving the lives of people living with Ophthalmic, central nervous, digestive and endocrine conditions using innovative science that ...
DelveInsight's "VERZENIO Market Size, Forecast, and Market Insight Report" highlights the details around VERZENIO, which is a ...
Goldman Sachs analyst Paul Choi downgraded Arvinas (ARVN) to Neutral from Buy with a price target of $15, down from $70, after the company ...
News-Medical.Net on MSN5d
These simple diet tweaks could slash microplastics in your bodyResearchers identify dietary and lifestyle-based strategies that may reduce human exposure to microplastics and nanoplastics.
News-Medical.Net on MSN3d
Tirzepatide helps people without diabetes lose 13% body weight in real-world studyA real-world study of over 4,000 US patients without type 2 diabetes found that those who persisted with Tirzepatide for at ...
West Virginia lawmakers have made history by passing a groundbreaking bill that bans a slate of artificial food dyes and ...
SAN DIEGO — GLP-1 agonists may be protective against hip fracture when administered for the treatment of type 2 diabetes, according to results presented here. Testosterone therapy plus lifestyle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback